Home/Filings/4/0001181431-04-043790
4//SEC Filing

BAKER BIOTECH CAPITAL GP LLC 4

Accession 0001181431-04-043790

CIK 0000911326other

Filed

Sep 13, 8:00 PM ET

Accepted

Sep 14, 9:17 PM ET

Size

13.7 KB

Accession

0001181431-04-043790

Insider Transaction Report

Form 4
Period: 2004-09-14
BAKER JULIAN
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2004-09-14$13.32/sh+20,850$277,7221,253,084 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2004-09-10$12.55/sh+31,275$392,6171,214,199 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2004-09-10$12.99/sh+1,355$17,6031,215,554 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2004-09-13$13.56/sh+16,680$226,1661,232,234 total(indirect: See Footnote)
Transactions
  • Purchase

    Common Stock

    2004-09-13$13.56/sh+16,680$226,1661,232,234 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2004-09-10$12.99/sh+1,355$17,6031,215,554 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2004-09-14$13.32/sh+20,850$277,7221,253,084 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2004-09-10$12.55/sh+31,275$392,6171,214,199 total(indirect: See Footnote)
BAKER FELIX
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2004-09-10$12.99/sh+1,355$17,6031,215,554 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2004-09-13$13.56/sh+16,680$226,1661,232,234 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2004-09-10$12.55/sh+31,275$392,6171,214,199 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2004-09-14$13.32/sh+20,850$277,7221,253,084 total(indirect: See Footnote)
Footnotes (2)
  • [F1]In addition to Baker Biotech Capital (GP), LLC, this Form 4 is being filed jointly by Julian C. Baker and Felix J. Baker, each of whom has the same business address as Baker Biotech Capital (GP), LLC and may be deemed to have a pecuniary interest in securities owned by it. Felix J. Baker and Julian C. Baker are directors of the Issuer. Because of certain relationships with other security holders of the Issuer, the Reporting Persons are filing solely for informational purposes as if they were members of a group with such security holders. However, the Reporting Persons disclaim that they and any other person or persons in fact constitute a "group" for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, or Rule 13d-5 thereunder or that they are the beneficial owners of securities owned by such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
  • [F2]Represents shares of common stock owned directly by Baker Biotech Fund I, L.P., the sole general partner of which is Baker Biotech Capital, L.P., a limited partnership of which the sole general partner is Baker Biotech Capital (GP), LLC. Felix J. Baker and Julian C. Baker are the controlling members of Baker Biotech Capital (GP), LLC.

Issuer

TRIMERIS INC

CIK 0000911326

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001244389

Filing Metadata

Form type
4
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 9:17 PM ET
Size
13.7 KB